The Effects of Early-Phase Furosemide Use on the Progression of Oliguric Acute Kidney Injury Across Different Central Venous Pressure: A Retrospective Analysis

Among the identified early-stage AKI patients in critical care, the use of furosemide was only associated with lower risk of oliguric AKI progression and 28-day mortality within the high CVP group. These findings suggest the potential of CVP as a guidance or reference point in the usage of furosemide among early-stage oliguric AKI patients in the ICU.